Colonix moves to Granta Park


Granta Park has let the first unit in its new Riverside development of smaller offices and R & D units to Colonix Medical, which researches and develops new products for the early and accurate detection of bowel disorders.

The company has taken 2640 sq ft on a five year term, moving from Babraham Research Campus, where it will still keep a research unit. Says Colonix Managing Director Hugo Lywood : “Babraham has suited us well for the last four years while we have been in research, but now that we are close to commercialisation our needs have changed and Granta Park exactly meets those needs.”

Colonix will have half a floor in Riverside, which is currently an open space ready for bespoke fit out. “This will allow us to have it exactly as we want it,” adds Hugo. “This will suit us for the next three years and then we will have the opportunity to expand at Granta Park. With most of our staff coming from south Cambridge – and they were unanimous about moving to Granta Park - it’s also a very good location.”
The deal was handled by Jeffersons Commercial, who are seeing a lot of interest in the development: “We are talking to a number of companies and had quite a few viewings,” said Jeffersons’ Will Mooney. “It’s a unique opportunity to be in an environment purpose built for smaller companies and has many advantages such as sports and social programme, meeting facilities, cafe, restaurant, nursery, fitness suite, commuter bus and 24 hour security normally associated with larger companies.”
To find out more about opportunities at the Riverside contact Will Mooney on 01223 315716
To read more information, click here.

BioMed Realty has been part of Cambridge's world-class life science community since the acquisition of Granta Park in 2012. Granta Park is a 477,230 square foot business estate in one of the most reconised areas for science success globally and is home to leading companies, including Sosei Heptares, Astrazeneca, Illumina, PPD Global, and One Nucleus.

BioMed Realty